Monday, December 23, 2024
Advertisement
  1. You Are At:
  2. News
  3. Sports
  4. Other
  5. Jithin Paul slapped four-year ban for possession of banned drug

Jithin Paul slapped four-year ban for possession of banned drug

Paul who is a 400m hurdles National Open champion becomes the first Indian athlete to be sanctioned for such an offence.

Edited by: India TV Sports Desk New Delhi Published : Feb 23, 2018 18:27 IST, Updated : Feb 23, 2018 18:27 IST
Jithin Paul slapped four-year ban for possession of banned drug
Image Source : JITHIN PAUL/FACEBOOK A file image of athlete Jithin Paul

Indian athlete Jithin Paul has been banned for four years after National Anti Doping Agency (NADA) found that the 400-metre hurdler was in possession of a prohibited substance called 'Meldonium'. With this ban, Paul becomes first Indian athlete to be sanctioned for such an offence. Paul is a 400m hurdles National Open champion and a 2016 South Asian Games silver medallist.

NADA, in an official statement, said, "The panel concludes that athlete Mr, Jithin Paul was in possession of prohibited substance i.e. Meldonium and violated the Article 2.6 of the Anti Doping rules of NADA 2015."

The statement further notified that the athlete has been found in possession of Meldonium in his room at National Institute of Sports, Patiala, Punjab, during the search by NADA in April 2017.

The Anti Doping agency clarified that Paul had no reasonable justification of the prohibited substance in his room.

What is "Meldonium"?

Since January 2016, Meldonium has been on the World Anti-Doping Agency (WADA) list of substances banned from use by athletes because of evidence of its use by athletes with the intention of enhancing performance.

On March 7, 2016, former world number one tennis player Maria Sharapova was handed a 15-month ban as she failed a drug test in Australia due to the detection of Meldonium. 

(With PTI Inputs)

Advertisement

Read all the Breaking News Live on indiatvnews.com and Get Latest English News & Updates from Sports and Other Section

Advertisement
Advertisement
Advertisement
Advertisement